RBFOX2 promotes tumor progression by acting as a splicer of EMT-related genes in several types of cancers (Shapiro et al., 2011; Braeutigam et al., 2014); however, the status and role of RBFOX2 in GC is unclear. Here, RBFOX2 is linked to neoplasm.